Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China flag China · Delayed Price · Currency is CNY
6.91
-0.03 (-0.43%)
Sep 10, 2026, 3:04 PM CST

SHE:300636 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
39.1873.09106.58105.98100.6781.12
Depreciation & Amortization
135.02131114.7769.3966.8851.58
Other Amortization
0.680.68----
Loss (Gain) From Sale of Assets
0.640.771.171.320.181.01
Asset Writedown & Restructuring Costs
-15.02-----0.04
Loss (Gain) From Sale of Investments
0.750.9-0.62-0.571.21-0.28
Provision & Write-off of Bad Debts
1.221.221.27-0.111.482.11
Other Operating Activities
87.7374.8539.7822.961510.48
Change in Accounts Receivable
-39.12-37.2-12.4922.41-11.52-61.27
Change in Inventory
-68.83-20.13-55.66-45.2-131.24-42.8
Change in Accounts Payable
87.1131.45100.72-23.01133.0185.34
Change in Other Net Operating Assets
-56.63-56.83-16.34.3314.85-3.12
Operating Cash Flow
165.38202.07285.19163.75196131.34
Operating Cash Flow Growth
-49.58%-29.14%74.16%-16.45%49.23%64.04%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-205.83-291.24-136.49-214.65-311.49-424.67
Sale of Property, Plant & Equipment
0.330.390.490.231.120.44
Investment in Securities
61.73273.57-370.33-493.96-30-20
Other Investing Activities
0.640.370.682.18-1.610.02
Investing Cash Flow
-143.13-16.91-505.65-706.21-341.99-444.21

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-459.89870.49924.7391.74427.46
Long-Term Debt Repaid
--526.73-937.36-770.72-285.68-211.16
Lease Payments
-1.11-1.11-1.1-1.06-1.11-0.48
Net Debt Issued (Repaid)
-170.61-66.84-66.87153.98106.06216.3
Issuance of Common Stock
---789.8241.42-
Repurchase of Common Stock
-12.34-12.34-12.98-0.43--
Common Dividends Paid
-27.61-28.78-29.12-26.91-32.11-21.8
Other Financing Activities
13.4310-238.8-46.8-6.82
Financing Cash Flow
-197.13-97.96-110.97955.2668.57187.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-7.920.234.051.821.13-0.74
Net Cash Flow
-182.887.43-327.39414.62-76.29-125.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-40.45-89.17148.7-50.9-115.5-293.33
Free Cash Flow Growth
------
Free Cash Flow Margin
-5.16%-10.76%19.59%-7.05%-16.04%-49.54%
Free Cash Flow Per Share
-0.10-0.210.35-0.13-0.33-0.87
Levered Free Cash Flow
-393.11-113.980.53-201.9-197.59-293.72
Unlevered Free Cash Flow
-385.29-106.1611.87-195.72-192.78-290.16
Free Cash Flow After Leases
-41.57-90.29147.6-51.96-116.6-293.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
--46.55-27.75-41.2-84.82-59.22
Change in Working Capital
-84.82-80.4422.24-35.2310.57-14.64